N'ime afọ ndị na-adịbeghị anya, ụlọ ọrụ nyocha nke in vitro (IVD) na-eto ngwa ngwa.Dị ka data wepụtara site Evaluate MedTech, site na 2014 ruo 2017, ụwa ahịa ahịa ọnụ ọgụgụ nke IVD ụlọ ọrụ amụbawo kwa afọ, site na $49 ijeri 900 nde na 2014 ruo $52 ijeri 600 nde na 2017, na kwa afọ composite ibu ọnụego nke. 1.8%;na 2024, ahịa ahịa ọnụ ọgụgụ na-atụ anya iru $79 ijeri 600 nde, si 2017 ka 2024 The compound kwa afọ uto ọnụego ruru 6.1%.N'okwu a, mkpa ụlọ ọgwụ na-abawanye na ụkpụrụ ngwa ngwa ụlọ ọrụ na-ebutekwa ihe ọhụrụ achọrọ maka ngwaahịa na teknụzụ IVD.Mgbe afọ iri nke nnwere onwe mmepe nke "Lica ìhè-induced chemiluminescence technology", dị ka a ọhụrụ chemiluminescent immunoassay usoro, Kemei nchoputa creatively adopts homogeneous mmeghachi omume usoro na nano elu-tech ahụ, na-enye ihe ngwọta ọhụrụ maka ọtụtụ ụlọ nyocha ụlọ ọgwụ.Dị ka data ọha na eze si kwuo, n'ọhịa nke chemiluminescence immunodiagnosis na China, a rụpụtawo nsonaazụ dị mma na mpaghara nke ọkara na obere njedebe immunodiagnosis.Otú ọ dị, n'ahịa chemiluminescence dị elu nke China, ndị na-emepụta ihe na-ebubata ka na-eji ihe karịrị 80% nke ahịa ahịa.N'ime ha, Abbott, Roche, Beckman na Siemens bụ ihe dịka 70% nke oke ahịa.Otú ọ dị, site na mmelite nke ọkwa oriri ahụike nke China, nkwalite usoro ọgwụgwọ ahụike na nkwado siri ike nke atumatu ụlọ ọrụ mmepụta ihe nke mba, anyị na-elekwasị anya na mmepe nke reagents nchọpụta in vitro, ma nwee olileanya ịkwado gị.